Histopathology of lung disease in the connective tissue diseases

Rheumatic Disease Clinics of North America

Volumn 41, Issue 2, 2015, Pages 197-211

  Vivero, Marina ^a   Padera, Robert F ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Connective tissue disease; Histopathology; Interstitial lung disease; Myositis; Pathology; Rheumatoid arthritis; Scleroderma

Indexed keywords

RIBONUCLEOPROTEIN ANTIBODY;

CONNECTIVE TISSUE DISEASE; CYTOLOGY; DIFFERENTIAL DIAGNOSIS; FIBROSING ALVEOLITIS; HISTOPATHOLOGY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFECTION SENSITIVITY; INTERSTITIAL LUNG DISEASE; INTERSTITIAL PNEUMONIA; LUNG DISEASE; MIXED CONNECTIVE TISSUE DISEASE; MYOSITIS; PLEURA FLUID; PRIORITY JOURNAL; PULMONARY HYPERTENSION; REVIEW; RHEUMATOID ARTHRITIS; SCLERODERMA; SJOEGREN SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS; BIOPSY; COMPLICATION; LUNG DISEASES; PATHOLOGY;

BIOPSY; CONNECTIVE TISSUE DISEASES; HUMANS; LUNG DISEASES;

EID: 84926176338     PISSN: 0889857X     EISSN: 15583163     Source Type: Journal    
DOI: 10.1016/j.rdc.2014.12.002     Document Type: Review

References (72)

1. Schneider F., Gruden J., Tazelaar H.D., et al. Pleuropulmonary pathology in patients with rheumatic disease. Arch Pathol Lab Med 2012, 136:1242-1252.
2. Tansey D., Wells A.U., Colby T.V., et al. Variations in histological patterns of interstitial pneumonia between connective tissue disorders and their relationship to prognosis. Histopathology 2004, 44:585-596.
3. Cipriani N.A., Strek M., Noth I., et al. Pathologic quantification of connective tissue disease-associated versus idiopathic usual interstitial pneumonia. Arch Pathol Lab Med 2012, 136:1253-1258.
4. Travis W.D., Costabel U., Hansell D.M., et al. An official American Thoracic Society/European Respiratory Society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med 2013, 188:733-748.
5. Yousem S.A., Colby T.V., Carrington C.B. Lung biopsy in rheumatoid arthritis. Am Rev Respir Dis 1985, 131:770-777.
6. Fathi M., Lundberg I.E. Interstitial lung disease in polymyositis and dermatomyositis. Curr Opin Rheumatol 2005, 17:701-706.
7. Kalluri M., Oddis C.V. Pulmonary manifestations of the idiopathic inflammatory myopathies. Clin Chest Med 2010, 31:501-512.
8. Macfarlane J.D., Dieppe P.A., Rigden B.G., et al. Pulmonary and pleural lesions in rheumatoid disease. Br J Dis Chest 1978, 72:288-300.
9. Hakala M., Pääkkö P., Huhti E., et al. Open lung biopsy of patients with rheumatoid arthritis. Clin Rheumatol 1990, 9:452-460.
10. Hashimoto K., Nakanishi H., Yamasaki A., et al. Pulmonary findings without the influence of therapy in a patient with rheumatoid arthritis: an autopsy case. JMed Invest 2007, 54:340-344.
11. De las Casas L.E., Morales A.M., Boman D.A., et al. Laparoscopic aspiration cytology in rheumatoid ascites: a case report. Acta Cytol 2010, 54:1123-1126.
12. Turesson C., Matteson E.L., Colby T.V., et al. Increased CD4+ T cell infiltrates in rheumatoid arthritis-associated interstitial pneumonitis compared with idiopathic interstitial pneumonitis. Arthritis Rheum 2005, 52:73-79.
13. Lee H.K., Kim D.S., Yoo B., et al. Histopathologic pattern and clinical features of rheumatoid arthritis-associated interstitial lung disease. Chest 2005, 127:2019-2027.
14. Yoshinouchi T., Ohtsuki Y., Fujita J., et al. Nonspecific interstitial pneumonia pattern as pulmonary involvement of rheumatoid arthritis. Rheumatol Int 2005, 26:121-125.
15. Atkins S.R., Turesson C., Myers J.L., et al. Morphologic and quantitative assessment of CD20+ B cell infiltrates in rheumatoid arthritis-associated nonspecific interstitial pneumonia and usual interstitial pneumonia. Arthritis Rheum 2006, 54:635-641.
16. Song J.W., Do K.H., Kim M.Y., et al. Pathologic and radiologic differences between idiopathic and collagen vascular disease-related usual interstitial pneumonia. Chest 2009, 136:23-30.
17. Nakamura Y., Suda T., Kaida Y., et al. Rheumatoid lung disease: prognostic analysis of 54 biopsy-proven cases. Respir Med 2012, 106:1164-1169.
18. Hozumi H., Nakamura Y., Johkoh T., et al. Acute exacerbation in rheumatoid arthritis-associated interstitial lung disease: a retrospective case control study. BMJ Open 2013, 3:e003132.
19. Kono M., Nakamura Y., Enomoto N., et al. Usual interstitial pneumonia preceding collagen vascular disease: a retrospective case control study of patients initially diagnosed with idiopathic pulmonary fibrosis. PLoS One 2014, 9:e94775.
20. Yousem S.A., Colby T.V., Carrington C.B. Follicular bronchitis/bronchiolitis. Hum Pathol 1985, 16:700-706.
21. Devouassoux G., Cottin V., Lioté H., et al. Characterisation of severe obliterative bronchiolitis in rheumatoid arthritis. Eur Respir J 2009, 33:1053-1061.
22. Parambil J.G., Myers J.L., Lindell R.M., et al. Interstitial lung disease in primary Sjögren syndrome. Chest 2006, 130:1489-1495.
23. Schwarz M.I., Zamora M.R., Hodges T.N., et al. Isolated pulmonary capillaritis and diffuse alveolar hemorrhage in rheumatoid arthritis and mixed connective tissue disease. Chest 1998, 113:1609-1615.
24. Fischer A., Swigris J.J., Groshong S.D., et al. Clinically significant interstitial lung disease in limited scleroderma: histopathology, clinical features and survival. Chest 2008, 134:601-605.
25. Kim E.A., Lee K.S., Johkoh T., et al. Interstitial lung diseases associated with collagen vascular diseases: radiologic and histopathologic findings. Radiographics 2002, 22:S151-S165.
26. Bouros D., Wells A.U., Nicholson A.G., et al. Histopathologic subsets of fibrosing alveolitis in patients with systemic sclerosis and their relationship to outcome. Am J Respir Crit Care Med 2002, 165:1581-1586.
27. Parra E.R., Otani L.H., de Carvalho E.F., et al. Systemic sclerosis and idiopathic interstitial pneumonia: histomorphometric differences in lung biopsies. JBras Pneumol 2009, 35:529-540.
28. Fujita J., Yoshinouchi T., Ohtsuki Y., et al. Non-specific interstitial pneumonia as pulmonary involvement of systemic sclerosis. Ann Rheum Dis 2001, 60:281-283.
29. Yousem S.A. The pulmonary pathologic manifestations of the CREST syndrome. Hum Pathol 1990, 21:467-474.
30. Griffin M.T., Robb J.D., Martin J.R. Diffuse alveolar haemorrhage associated with progressive systemic sclerosis. Thorax 1990, 45:903-904.
31. Duncan P.E., Griffin J.P., Garcia A., et al. Fibrosing alveolitis in polymyositis. A review of histologically confirmed cases. Am J Med 1974, 57:621-626.
32. Schwarz M.I., Matthay R.A., Sahn S.A., et al. Interstitial lung disease in polymyositis and dermatomyositis: analysis of six cases and review of the literature. Medicine (Baltimore) 1976, 55:89-104.
33. Douglas W.W., Tazelaar H.D., Hartman T.E., et al. Polymyositis-dermatomyositis-associated interstitial lung disease. Am J Respir Crit Care Med 2001, 164:1182-1185.
34. Cottin V., Thivolet-Béjui F., Reynaud-Gaubert M., et al. Interstitial lung disease in amyopathic dermatomyositis, dermatomyositis and polymyositis. Eur Respir J 2003, 22:245-250.
35. Koreeda Y., Higashimoto I., Yamamoto M., et al. Clinical and pathological findings of interstitial lung disease patients with anti-aminoacyl-tRNA synthetase autoantibodies. Intern Med 2010, 49:361-369.
36. Tazelaar H.D., Viggiano R.W., Pickersgill J., et al. Interstitial lung disease in polymyositis and dermatomyositis. Clinical features and prognosis as correlated with histologic findings. Am Rev Respir Dis 1990, 141:727-733.
37. Matsuki Y., Yamashita H., Takahashi Y., et al. Diffuse alveolar damage in patients with dermatomyositis: a six-case series. Mod Rheumatol 2012, 22:243-248.
38. Schwarz M.I., Sutarik J.M., Nick J.A., et al. Pulmonary capillaritis and diffuse alveolar hemorrhage. A primary manifestation of polymyositis. Am J Respir Crit Care Med 1995, 151:2037-2040.
39. Kinney W.W., Angelillo V.A. Bronchiolitis in systemic lupus erythematosus. Chest 1982, 82:646-649.
40. Wiedemann H.P., Matthay R.A. Pulmonary manifestations of systemic lupus erythematosus. JThorac Imaging 1992, 7:1-18.
41. Zamora M.R., Warner M.L., Tuder R., et al. Diffuse alveolar hemorrhage and systemic lupus erythematosus. Clinical presentation, histology, survival, and outcome. Medicine (Baltimore) 1997, 76:192-202.
42. Keane M.P., Lynch J.P. Pleuropulmonary manifestations of systemic lupus erythematosus. Thorax 2000, 55:159-166.
43. Kim J.S., Lee K.S., Koh E.M., et al. Thoracic involvement of systemic lupus erythematosus: clinical, pathologic, and radiologic findings. JComput Assist Tomogr 2000, 24:9-18.
44. Lamblin C., Bergoin C., Saelens T., et al. Interstitial lung diseases in collagen vascular diseases. Eur Respir J Suppl 2001, 32:69s-80s.
45. Haupt H.M., Moore G.W., Hutchins G.M. The lung in systemic lupus erythematosus. Analysis of the pathologic changes in 120 patients. Am J Med 1981, 71:791-798.
46. Lynch J.P., Hunninghake G.W. Pulmonary complications of collagen vascular disease. Annu Rev Med 1992, 43:17-35.
47. Cheema G.S., Quismorio F.P. Interstitial lung disease in systemic lupus erythematosus. Curr Opin Pulm Med 2000, 6:424-429.
48. Matthay R.A., Schwarz M.I., Petty T.L., et al. Pulmonary manifestations of systemic lupus erythematosus: review of twelve cases of acute lupus pneumonitis. Medicine (Baltimore) 1975, 54:397-409.
49. Gammon R.B., Bridges T.A., al-Nezir H., et al. Bronchiolitis obliterans organizing pneumonia associated with systemic lupus erythematosus. Chest 1992, 102:1171-1174.
50. Gutsche M., Rosen G.D., Swigris J.J. Connective tissue disease-associated interstitial lung disease: a review. Curr Respir Care Rep 2012, 1:224-232.
51. Eagen J.W., Memoli V.A., Roberts J.L., et al. Pulmonary hemorrhage in systemic lupus erythematosus. Medicine (Baltimore) 1978, 57:545-560.
52. Pines A., Kaplinsky N., Olchovsky D., et al. Pleuro-pulmonary manifestations of systemic lupus erythematosus: clinical features of its subgroups. Prognostic and therapeutic implications. Chest 1985, 88:129-135.
53. Weinrib L., Sharma O.P., Quismorio F.P. Along-term study of interstitial lung disease in systemic lupus erythematosus. Semin Arthritis Rheum 1990, 20:48-56.
54. Eisenberg H., Dubois E.L., Sherwin R.P., et al. Diffuse interstitial lung disease in systemic lupus erythematosus. Ann Intern Med 1973, 79:37-45.
55. Ito I., Nagai S., Kitaichi M., et al. Pulmonary manifestations of primary Sjögren's syndrome: a clinical, radiologic, and pathologic study. Am J Respir Crit Care Med 2005, 171:632-638.
56. Shi J.H., Liu H.R., Xu W.B., et al. Pulmonary manifestations of Sjögren's syndrome. Respiration 2009, 78:377-386.
57. Strimlan C.V., Rosenow E.C., Divertie M.B., et al. Pulmonary manifestations of Sjögren's syndrome. Chest 1976, 70:354-361.
58. Dalvi V., Gonzalez E.B., Lovett L. Lymphocytic interstitial pneumonitis (LIP) in Sjögren's syndrome: a case report and a review of the literature. Clin Rheumatol 2007, 26:1339-1343.
59. Kokosi M., Riemer E.C., Highland K.B. Pulmonary involvement in Sjögren syndrome. Clin Chest Med 2010, 31:489-500.
60. Papiris S.A., Maniati M., Constantopoulos S.H., et al. Lung involvement in primary Sjögren's syndrome is mainly related to the small airway disease. Ann Rheum Dis 1999, 58:61-64.
61. Hant F.N., Herpel L.B., Silver R.M. Pulmonary manifestations of scleroderma and mixed connective tissue disease. Clin Chest Med 2010, 31:433-449.
62. Watanabe Y., Koyama S., Moriguchi M., et al. Rapidly progressive respiratory failure in mixed connective tissue disease: report of an autopsy case. Intern Med 2012, 51:3415-3419.
63. Bull T.M., Fagan K.A., Badesch D.B. Pulmonary vascular manifestations of mixed connective tissue disease. Rheum Dis Clin North Am 2005, 31:451-464.
64. Bryson T., Sundaram B., Khanna D., et al. Connective tissue disease-associated interstitial pneumonia and idiopathic interstitial pneumonia: similarity and difference. Semin Ultrasound CT MR 2014, 35:29-38.
65. Sullivan W.D., Hurst D.J., Harmon C.E., et al. Aprospective evaluation emphasizing pulmonary involvement in patients with mixed connective tissue disease. Medicine (Baltimore) 1984, 63:92-107.
66. Perez-Alvarez R., Perez-de-Lis M., Diaz-Lagares C., et al. Interstitial lung disease induced or exacerbated by TNF-targeted therapies: analysis of 122 cases. Semin Arthritis Rheum 2011, 41:256-264.
67. Aubry M.C. Necrotizing granulomatous inflammation: what does it mean if your special stains are negative?. Mod Pathol 2012, 25:S31-S38.
68. Myers J.L., Limper A.H., Swensen S.J. Drug-induced lung disease: a pragmatic classification incorporating HRCT appearances. Semin Respir Crit Care Med 2003, 24:445-454.
69. Carrillo J., Restrepo C.S., Rosado de Christenson M., et al. Lymphoproliferative lung disorders: a radiologic-pathologic overview. Part I: reactive disorders. Semin Ultrasound CT MR 2013, 34:525-534.
70. Herbert A., Walters M.T., Cawley M.I., et al. Lymphocytic interstitial pneumonia identified as lymphoma of mucosa associated lymphoid tissue. JPathol 1985, 146:129-138.
71. Kradin R.L., Mark E.J. Benign lymphoid disorders of the lung, with a theory regarding their development. Hum Pathol 1983, 14:857-867.
72. Swigris J.J., Berry G.J., Raffin T.A., et al. Lymphoid interstitial pneumonia: a narrative review. Chest 2002, 122:2150-2164.